Please login to the form below
vaccines
This page shows the latest vaccines news and features for those working in and with pharma, biotech and healthcare.
Catalent preps for complex therapy boom with $1.2bn Paragon buy
Paragon, which is backed by private-equity firms Camden Partners and NewSpring Capital, helps its clients develop and produce gene therapies, next-generation vaccines, and other complex biopharmaceuticals such as oncolytic
Latest news
-
Roivant forms Asian cell therapy ‘vant’, with Medigene’s help
The deal with Medigene covers rights to a research-stage T cell receptor (TCR) against tumour antigen NY-ESO-1 and Medigene’s dendritic cell vaccine targeting WT-1 and PRAME
-
UK biotech bags €1.5m grant for new antibiotic class
Danish biotech Minervax claimed 3.6m for a prophylactic vaccine against Group B Streptococcus (GBS) responsible for 50% of life-threatening infections in newborns as well as stillbirths and preterm deliveries
-
Gene Genie
Look carefully and we can see it working. In Poland, new grandparents are buying vaccines instead of silver gifts.
-
Pharma industry swamped with no-deal Brexit info, says BIA
After analysing the supply chains of 12, 300 medicines, almost half a million devices and clinical consumables, vaccines and essential non-clinical items “we are confident that, if everyone…does what
-
Novartis and Syncona back new Swiss biotech Anaveon
including combination with cell therapies, vaccines, checkpoint inhibitors and radiotherapy.
More from news
Approximately 93 fully matching, plus 987 partially matching documents found.
Latest Intelligence
-
Combining therapies and combining research
Of course, other strategies also play their part: improved antibiotic stewardship, good infection control, publicity about AMR, more effective vaccines, less use of antibiotics in agriculture, fast diagnostic testing, more professionals
-
The UK’s new five-year pricing agreement
This means that people across the UK should see better and faster access to the most effective new medicines and vaccines.”.
-
Innovation in merger control and the impact on the pharmaceutical sector
In the 1995 AMP/Wyeth merger, the parties divested one of the two development programmes for rotavirus vaccines to the Korean Green Cross. ... More than ten years later, GSK launched a rival vaccine, while the Korean Green Cross never did.
-
The handover: Pfizer reshapes itself for a new era
new therapies and vaccines.
-
In conversation with Pfizer’s Erik Nordkamp
The Life Sciences Industrial Strategy could increase the speed with which new medicines and vaccines are made available across the UK, if implemented in full and with the involvement and commitment
More from intelligence
Approximately 4 fully matching, plus 81 partially matching documents found.
Latest appointments
-
Bone Therapeutics strengthens board with new chairman
He has also been a member of the corporate executive team for GlaxoSmithKline and chief executive officer of GSK Biologicals (now GSK Vaccines).
-
McCann Health appoints Daniel Carucci as global medical director
Dr Carucci has over 25 years of experience in large-scale innovation programs, vaccine development, organisational leadership, and global public health, during which time he served as VP for global health
-
Professor Carole Longson moves from NICE to the ABPI
and the role our members play in developing new innovative medicines and vaccines.
-
Lilly bolsters its oncology team
Furthermore, she has been on the forefront of research in oncology vaccines, immuno-oncology and biosimilars, giving her the unique expertise that will be pivotal in helping us continue to develop
-
Relay Therapeutics appoints Sarah O’Brien as VP of HR
Prior to Sobi, O’Brien spent seven years working at Novartis for its vaccines arm and then with the Novartis Institute for Biomedical Research (NIBR), where she worked closely with the
More from appointments
Approximately 5 fully matching, plus 61 partially matching documents found.
Latest from PMHub
-
Red Consultancy expands healthcare team with three new hires
Jordan has therapy area experience across oncology, flu, travel vaccines, CMV and diabetes, and is highly skilled at both traditional and social media relations.
-
Vaccines: Our experience and expertise
We have designed a complimentary infographic outlining the market opportunity as well as our experience and expertise in the area of vaccines.
-
World AIDS Day 2018: Fighting the stigma surrounding HIV
Therapeutic vaccine – although unlikely to be a cure, this vaccine could help control viral load for those living with HIV, thus removing the need for antiretrovirals. ... Available at: . Accessed November 2018. The history of vaccines. The Development
-
Money, sex and power
Social history will record that whilst vaccines, nylon, biotech, the jet engine, the silicon chip, networks, social media and nuclear energy all seemed like big ideas we’ve only just made
-
PRMA Consulting Ltd
Our experience encompasses a wide range of indications, including; cardiovascular and renal, gastroenterology, immunology, infectious diseases and vaccines, metabolism and endocrinology, neurology and psychiatry, oncology/hematology, ophthalmology,
More from PMHub
Approximately 4 fully matching, plus 22 partially matching documents found.
Featured jobs
- Project Manager - Medical Communications – South Wales
-
Excellent Remuneration Package
- Account Manager / Senior Account Manager - Healthcare Advertisin...
-
Excellent Remuneration
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
- Editor – Medical Education Agency – Bucks
-
Salary TBC
-
Senior Medical Writer
-
Salary TBC
- Account Director – London based Medical Communications Agency
-
Excellent Remuneration Package
- Senior Account Manager- Pharma and Life Scienes
-
Competitive salary and benefits
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Senior / Principal Medical Writer - MedComms - Home Based / Vari...
-
Excellent Remuneration Packages
- Project Manager - Digital Healthcare - London
-
Excellent Remuneration Package
- Senior Account Director/ Associate Director- Pharma and Life Sci...
-
Competitive salary and benefits
- Freelance Medical Writer - Healthcare Advertising - London
-
Employment Type:. Type of Job:. Region:. Salary:. 250 to 330 per day
-
Account Director, Medical Education
-
Salary TBC
-
Director – Healthcare PR
-
Salary TBC
-
Senior Medical Writer
-
Competitive salary and benefits
- Experienced / Senior Account Director - Publications - London
-
Up to £80, 000 plus great benefits
Subscribe to our email news alerts
- With Spiriva under pressure, Boehringer moves to bolster pipeline
- Genfit claims FDA breakthrough status for liver disease drug
- Mereo’s shareholders back OncoMed takeover
- Lucid Group announces the appointment of new CFO
- From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
- Q&A: Niels Lund
Latest intelligence
- From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
- How pharma is progressing their commitment in patient engagement...
- Cuttsy+Cuttsy awarded CPD Platinum by the IPA
- Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
- Breaking Bad
- Six behaviours separate the good brand teams from the bad...
Quick links
Infographics
